ANGIODYNAMICS INC. DL-,01 logo

ANGIODYNAMICS INC. DL-,01 (UG2)

Market Closed
28 Feb, 20:00
9. 00
-0.05
-0.55%
868.25M Market Cap
- P/E Ratio
0% Div Yield
0 Volume
-0.39 Eps
9.05
Previous Close
Day Range
9 9
Year Range
4.76 12.6
Earnings results expected in 22 days

Summary

UG2 closed Friday lower at €9, a decrease of 0.55% from Thursday's close, completing a monthly decrease of -18.92% or €2.1. Over the past 12 months, UG2 stock gained 3.45%.
UG2 is not paying dividends to its shareholders.
The last earnings report, released on Jan 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Apr 02, 2025.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track UG2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

UG2 Chart

ANGIODYNAMICS INC. DL-,01 (UG2) FAQ

What is the stock price today?

The current price is €9.00.

On which exchange is it traded?

ANGIODYNAMICS INC. DL-,01 is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is UG2.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 868.25M.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Apr 02, 2025.

Has ANGIODYNAMICS INC. DL-,01 ever had a stock split?

No, there has never been a stock split.

ANGIODYNAMICS INC. DL-,01 Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. James C. Clemmer CEO
XBER Exchange
US03475V1017 ISIN
United States Country
748 Employees
- Last Dividend
- Last Split
27 May 2004 IPO Date

Overview

AngioDynamics, Inc. is a prominent provider of invasive medical devices, catering to the needs of professional healthcare providers across the United States and internationally. The company specializes in a broad spectrum of medical areas, including vascular access, surgery, peripheral vascular disease, and oncology. Established in 1988, AngioDynamics is committed to enhancing patient outcomes through its innovative technologies and solutions, headquartered in Latham, New York.

Products and Services

  • Auryon Atherectomy System: A cutting-edge solution for the treatment of peripheral arterial disease. This system utilizes an optimized wavelength, pulse width, and amplitude to efficiently remove lesions while preserving the vessel wall endothelium.
  • Thrombus Management Portfolio:
    • AlphaVac System: A mechanical aspiration device designed for emergent situations, obviating the need for perfusionist support.
    • Thrombolytic Catheters: These are used to deliver drugs known as thrombolytic agents, intended to dissolve blood clots found in hemodialysis access grafts, arteries, veins, and surgical bypass grafts.
    • AngioVac Circuit: Designed for extracorporeal circulatory support for up to six hours. This includes a pump, filter, and reinfusion cannula to facilitate venous drainage during bypass procedures.
  • NanoKnife IRE Ablation System: Offers a non-traditional thermal approach for the surgical ablation of soft tissue, providing an alternative to conventional methods.
  • Peripheral Products: This category includes a range of products such as angiographic catheters, diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. These are essential tools for peripheral diagnostic and interventional procedures.
  • Drainage Catheters: A diverse range of catheters for various purposes, including multi-purpose/general, nephrostomy, and biliary drainage.
  • Micro Access Kits: Provides interventional physicians with a smaller introducer system for conducting minimally invasive procedures.
  • VenaCure EVLT System: Utilized in endovascular laser procedures to treat superficial venous disease, showcasing the company's commitment to vascular health.
  • Solero MTA System: Comprising the Solero microwave generator and specially designed Solero MW applicators, this system targets microwave thermal ablation processes.

Contact Information

Address: 14 Plaza Drive
Phone: 518 795 1400